Abstract
The heterogeneous morphological, biochemical and functional characteristics of mast cells from different species and from different tissue sites in the same species have been described for over 30 years. Far from being mere histochemical or pharmacological curiosities these differences have far reaching implications for therapeutic practice. This review concentrates on two important areas affected by mast cell heterogeneity, those of adverse reactions to therapeutic agents and the efficacy of anti-allergy therapy.
| Original language | English |
|---|---|
| Pages (from-to) | 147-154 |
| Number of pages | 8 |
| Journal | Inflammation Research |
| Volume | 49 |
| Issue number | 4 |
| Publication status | Published - 2000 |
ASJC Scopus subject areas
- Toxicology
- Pharmacology (medical)
- Immunology
- Cell Biology
Fingerprint Dive into the research topics of 'Clinical consequences of mast cell heterogeneity'. Together they form a unique fingerprint.
Cite this
Forsythe, P., & Ennis, M. (2000). Clinical consequences of mast cell heterogeneity. Inflammation Research, 49(4), 147-154.